End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.8 CNY | +0.41% | +14.75% | -9.43% |
Mar. 05 | Beijing Aosaikang Pharma's Unit Gets Nod to Market Delafloxacin for Injection | MT |
Jan. 23 | Aosaikang Pharmaceutical Registers Breast Cancer Drug | MT |
Sales 2021 | 3.11B 429M | Sales 2022 | 1.87B 258M | Capitalization | 7.37B 1.02B |
---|---|---|---|---|---|
Net income 2021 | 380M 52.44M | Net income 2022 | -226M -31.19M | EV / Sales 2021 | 3.26 x |
Net cash position 2021 | 1.67B 231M | Net cash position 2022 | 1.55B 215M | EV / Sales 2022 | 3.11 x |
P/E ratio 2021 |
31
x | P/E ratio 2022 |
-33.1
x | Employees | 1,215 |
Yield 2021 |
0.79% | Yield 2022 |
-
| Free-Float | 18.22% |
1 day | +0.41% | ||
1 week | +14.75% | ||
Current month | -7.28% | ||
1 month | +2.94% | ||
3 months | -1.90% | ||
6 months | +11.49% | ||
Current year | -9.43% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Fei Ma
CEO | Chief Executive Officer | 36 | 19-09-29 |
Tao Han
DFI | Director of Finance/CFO | 42 | 19-02-17 |
You Yin Xu
BRD | Director/Board Member | 56 | 19-02-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Wen Liu
BRD | Director/Board Member | 65 | 19-02-17 |
Qing Chen
CHM | Chairman | 65 | 19-02-17 |
You Yin Xu
BRD | Director/Board Member | 56 | 19-02-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 9.8 | +0.41% | 5,313,910 |
24-04-25 | 9.76 | +3.06% | 4,616,010 |
24-04-24 | 9.47 | -1.25% | 7,732,200 |
24-04-23 | 9.59 | +9.98% | 6,253,600 |
24-04-22 | 8.72 | +2.11% | 4,787,309 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.43% | 1.25B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- 002755 Stock